Location History:
- Halle, DE (2002)
- Halle/Saale, DE (2003 - 2008)
Company Filing History:
3 out of 71 
2 out of 16 
1 out of 1 Years Active: 2002-2008
Title: Konrad Glund: Innovator in Medical Treatments
Introduction
Konrad Glund is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of medical treatments, particularly through his innovative use of dipeptidyl peptidase IV inhibitors. With a total of 6 patents to his name, Glund's work has the potential to impact various medical conditions.
Latest Patents
One of Glund's latest patents focuses on the use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis. This invention provides a new application for DP IV-inhibitors, which are useful in treating conditions mediated by DP IV or DP IV-like enzymes. These conditions include immune, autoimmune, or central nervous system disorders such as strokes, tumors, ischemia, Parkinson's disease, and migraines. In a more preferred embodiment, the compounds are specifically aimed at treating multiple sclerosis. Another significant patent involves novel compounds of unstable DP IV-inhibitors, which are utilized in treating various disorders, especially metabolic disorders. These compounds can address issues such as impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy, and nephropathy.
Career Highlights
Throughout his career, Konrad Glund has worked with several prominent companies, including Probiodrug AG and Prosidion Limited. His innovative approaches and research have positioned him as a key figure in the development of new medical treatments.
Collaborations
Glund has collaborated with notable professionals in his field, including Hans-Ulrich Demuth and Torsten Hoffmann. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Konrad Glund's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments that could significantly improve patient outcomes.